Member Info for sphinx100

Someone’s mopping these up at the lower prices over the last 3 or 4 weeks ,IF come on there must be something worth reporting !

https://www.telegraph.co.uk/property/uk/house-prices-rising-fastest-rate-two-decades/

We know most of what will be said regarding income ,I’m hoping we get a bit more info on the DSM / ByHealth agreements , and progress on blue cap ,but I won’t be holding my breath

That was H1 , H2 full year was £173k ,so £28k losses in second half .

Looking at the figures again the loss in the second half were £28k , very close to break even !

https://www.dailymail.co.uk/money/investing/article-11174191/Is-time-home-housebuilders-Shares-cheap.html

https://www.dailymail.co.uk/money/investing/article-11174191/Is-time-home-housebuilders-Shares-cheap.html

http://www.by-health.com/en/aboutus/news/4577/

Could be a placing then, I would expect an Rns In the next few days if that’s the case !imho

Someones fed up of waiting ,,10 000000 sell gone through ,if it is a sell of course

Clearly with the order numbers rising about 3200 a month at retail price of say £15 would equal £48k per month and we’re nowhere near that !

As we already know what to expect in the full year results ,this could continue until first half results in Dec , better not to look daily ,put them in the bottom draw until some news ,enjoy the summer sun and come back in the Autumn .

With this statement “By-Health has recently updated its website (see www.by-health.com/en/aboutus) stating that it has completed: 'Research comprehensively in the cardiovascular health area. We have developed a new product made with Fruitflow®, popularly known as 'natural Aspirin'. It helps to maintain normal platelet aggregation.'”. It’s clear that the last 3 studies are for a different claim imo

Just need a cure for cancer and we’ll have the full set , IP would be worth £billion s imo

And if you take that’s with this snippet “By-Health currently expects to be in a position to complete the last of its eight studies in 2022, and it will file its regulatory submission to the SAMR for Fruitflow at the appropriate time “ to much of a coincidence in my mind , imho

Looks like IF is gearing everything Towards Jan 1st 2023. !The Company looks forward to welcoming and serving the majority of DSM's existing customers for Fruitflow from January next year, and is very pleased to be taking over control of the supply chain / production process for Fruitflow at the same time. There will be some clear synergies from January 2023 as the Company will be looking to sell Fruitflow to: (i) former DSM customers for Fruitflow; (ii) DSM and its Premix and Market-Ready Solutions businesses; (iii) new customers for Fruitflow as a straight ingredient; and (iv) By-Health and its customers, through the Company's long term supply and distribution agreement for Fruitflow with By-Health. Provexis will continue to sell its Fruitflow+ Omega-3 dietary supplement product direct to consumers, and serve its Chinese Cross-Border e-commerce distributor for this product in China. Subscriber numbers on the www.fruitflowplus.com website remain at an all-time high level.

https://www.marketwatch.com/story/provexis-shares-rise-after-securing-of-two-agreements-for-fruitflow-271655885402

https://www.morningstar.co.uk/uk/news/AN_1655891559848228000/in-brief-provexis-expects-substantial-increase-in-full-year-revenue.aspx

https://www.dsm.com/human-nutrition/en/customized-services/customized-solutions/health-benefit-solutions/improve-your-gut-health.html

My impression of By-Health as a company is that they are trying to do the right thing and change the attitude towards Chinese companies globally , they certainly make all the right noises hence the need to get Samr approval (otherwise why bother ) I take their persistance to get approval as a good indication of their ambition .